Evaluation of the analytical performances of the Cobas c513 analyser for HbA assay.
Fiche publication
Date publication
octobre 2018
Journal
Biochemia medica
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GILLERY Philippe
Tous les auteurs :
Jaisson S, Leroy N, Soulard M, Desmons A, Guillard E, Gillery P
Lien Pubmed
Résumé
Haemoglobin A (HbA) is considered to be the gold standard for the follow-up of glycaemic control in patients with diabetes mellitus and is also a diagnostic tool. Accordingly, reliable and efficient methods must be used for its quantification. Roche Diagnostics have recently adapted the Tina-quant® HbA Third Generation immunoassay on a fully dedicated analyser, the Cobas c513, which allows a high throughput of up to 400 samples hour. The present article deals with the evaluation of the analytical performances of this system which has been recently introduced to the market.
Mots clés
HbA1c, diabetes, evaluation, immunoassay
Référence
Biochem Med (Zagreb). 2018 Oct 15;28(3):030708